1. Home
  2. CELU vs NEUE Comparison

CELU vs NEUE Comparison

Compare CELU & NEUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • NEUE
  • Stock Information
  • Founded
  • CELU 2016
  • NEUE 2015
  • Country
  • CELU United States
  • NEUE United States
  • Employees
  • CELU N/A
  • NEUE N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • NEUE
  • Sector
  • CELU Health Care
  • NEUE
  • Exchange
  • CELU Nasdaq
  • NEUE NYSE
  • Market Cap
  • CELU 42.2M
  • NEUE 61.3M
  • IPO Year
  • CELU N/A
  • NEUE 2021
  • Fundamental
  • Price
  • CELU $2.24
  • NEUE $6.75
  • Analyst Decision
  • CELU
  • NEUE Hold
  • Analyst Count
  • CELU 0
  • NEUE 1
  • Target Price
  • CELU N/A
  • NEUE $7.00
  • AVG Volume (30 Days)
  • CELU 72.0K
  • NEUE 7.7K
  • Earning Date
  • CELU 05-08-2025
  • NEUE 08-06-2025
  • Dividend Yield
  • CELU N/A
  • NEUE N/A
  • EPS Growth
  • CELU N/A
  • NEUE N/A
  • EPS
  • CELU N/A
  • NEUE N/A
  • Revenue
  • CELU $54,220,000.00
  • NEUE $907,349,000.00
  • Revenue This Year
  • CELU $23.29
  • NEUE $33.99
  • Revenue Next Year
  • CELU N/A
  • NEUE $5.90
  • P/E Ratio
  • CELU N/A
  • NEUE N/A
  • Revenue Growth
  • CELU 138.11
  • NEUE N/A
  • 52 Week Low
  • CELU $1.00
  • NEUE $3.79
  • 52 Week High
  • CELU $5.22
  • NEUE $7.66
  • Technical
  • Relative Strength Index (RSI)
  • CELU 60.42
  • NEUE 42.09
  • Support Level
  • CELU $1.82
  • NEUE $6.79
  • Resistance Level
  • CELU $2.11
  • NEUE $6.91
  • Average True Range (ATR)
  • CELU 0.17
  • NEUE 0.08
  • MACD
  • CELU 0.03
  • NEUE -0.01
  • Stochastic Oscillator
  • CELU 95.44
  • NEUE 0.00

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About NEUE NEUEHEALTH INC

NeueHealth Inc is a value-driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated healthcare. It consists of two reportable segments: NeueCare - it's a value-driven care delivery business that manages risk in partnership with external payors and serves all populations across The Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act. NeueSolutions - it's a provider enablement business that includes a suite of technology, services, and clinical care solutions that empower providers to thrive in performance-based arrangements.

Share on Social Networks: